Lucid Engage vs Otofonix Groove

The Lucid Engage is a mid-priced behind-the-ear OTC hearing aid that earns an A grade with a SoundScore of 4.2/5 in our lab testing. Priced at $850, it ranks #14 among 65 OTC hearing aids tested, placing it in the top 20% of its category. Speech performance is a notable strength. Speech in quiet scores a strong 4.3/5, which is 1.46 points above the OTC category average of 2.79/5. Speech in noise comes in at 2.4/5—above the category average by 0.94 points, though only mixed in absolute terms at 2.4/5. Own-voice comfort is solid at 3.6/5, exceeding the category average by 1.09 points. The Engage does have limitations. Feedback handling scores 2.6/5, falling 1.94 points below the category average of 4.54/5. Music streaming is mixed at 2.4/5, though still 0.48 points above the OTC average. These results suggest the device prioritizes speech clarity over other use cases. This rechargeable BTE supports both iPhone and Android streaming. It received HearAdvisor's Expert's Choice Award in both 2023 and 2024. The Lucid Engage is best suited for consumers who prioritize conversational clarity and want an A-grade performer without prescription-level prices, though those sensitive to feedback or who stream music frequently may want to consider alternatives like the higher-scoring Sony CRE-E10 or Yeasound RIC800 in the same price range.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.